Lyell Immunopharma shares owned by UBS Group
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $444k | 199k | 2.23 |
| 2023-12-31 | $421k | 219k | 1.92 |
| 2023-09-30 | $287k | 195k | 1.47 |
| 2023-06-30 | $487k | 153k | 3.18 |
| 2023-03-31 | $522k | 221k | 2.36 |
| 2022-12-31 | $1.4M | 411k | 3.47 |
| 2022-09-30 | $150k | 20k | 7.40 |
| 2022-06-30 | $34k | 5.2k | 6.60 |
| 2022-03-31 | $25k | 5.0k | 5.00 |
| 2021-12-31 | $112k | 14k | 7.76 |
| 2021-09-30 | $4.0k | 268 | 14.93 |